The Company is not providing consolidated full year guidance, as Bausch + Lomb has not provided full year guidance. Bausch Health has provided guidance for the full year of 2023 as follows: Full-year revenue range of $4.45 – $4.6 billionl Full-year adjusted EBITDA range of $2.3 – $2.4 billion.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BHC: